Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Europe B.V.
With
World Health Information Science Consultants, LLC
All eligible patients treated with a parenteral antifungal agent at any time during the years 2005-2012 in each of the participating hospitals, will be included in the study.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
hospitalized and treated with parenteral antifungal medication
first time treatment of the patient with parenteral antifungal in the medical center was anytime from 2005 through 2012
You may not be if
prior diagnosis of hepatocellular carcinoma
had received parenteral antifungal therapy during the 6 months prior to index hospitalization
Clareo Health | Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
